Hsiang-Ping Wang

Role of fibroblast growth factor 23 in predicting CKD progression and prognosis: a systematic review and meta-analysis

Background and Objectives Chronic kidney disease (CKD) affects 10% of the global population. This meta-analysis evaluated fibroblast growth factor 23 (FGF-23) as a prognostic biomarker for CKD progression, kidney failure, cardiovascular events, and mortality. Materials and Method...